198 related articles for article (PubMed ID: 14565760)
1. Reactivity with Tris(hydroxymethyl)aminomethane confounds immunodetection of acrolein-adducted proteins.
Burcham PC; Fontaine FR; Petersen DR; Pyke SM
Chem Res Toxicol; 2003 Oct; 16(10):1196-201. PubMed ID: 14565760
[TBL] [Abstract][Full Text] [Related]
2. Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytes.
Kaminskas LM; Pyke SM; Burcham PC
Chem Res Toxicol; 2005 Nov; 18(11):1627-33. PubMed ID: 16300370
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
[TBL] [Abstract][Full Text] [Related]
4. Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity.
Burcham PC; Fontaine FR; Kaminskas LM; Petersen DR; Pyke SM
Mol Pharmacol; 2004 Mar; 65(3):655-64. PubMed ID: 14978244
[TBL] [Abstract][Full Text] [Related]
5. Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice.
Kaminskas LM; Pyke SM; Burcham PC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1003-10. PubMed ID: 15131244
[TBL] [Abstract][Full Text] [Related]
6. Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugs.
Kaminskas LM; Pyke SM; Burcham PC
Rapid Commun Mass Spectrom; 2007; 21(7):1155-64. PubMed ID: 17318925
[TBL] [Abstract][Full Text] [Related]
7. Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection.
Burcham PC; Pyke SM
Mol Pharmacol; 2006 Mar; 69(3):1056-65. PubMed ID: 16368895
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of acrolein-protein adducts: potential biomarker of acrolein exposure.
Li H; Wang J; Kaphalia B; Ansari GA; Khan MF
J Toxicol Environ Health A; 2004 Mar; 67(6):513-24. PubMed ID: 14742096
[TBL] [Abstract][Full Text] [Related]
9. Intermolecular protein cross-linking during acrolein toxicity: efficacy of carbonyl scavengers as inhibitors of heat shock protein-90 cross-linking in A549 cells.
Burcham PC; Raso A; Thompson C; Tan D
Chem Res Toxicol; 2007 Nov; 20(11):1629-37. PubMed ID: 17907782
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody against protein-bound glutathione: use of glutathione conjugate of acrolein-modified proteins as an immunogen.
Furuhata A; Honda K; Shibata T; Chikazawa M; Kawai Y; Shibata N; Uchida K
Chem Res Toxicol; 2012 Jul; 25(7):1393-401. PubMed ID: 22716076
[TBL] [Abstract][Full Text] [Related]
11. Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry.
Carini M; Aldini G; Beretta G; Arlandini E; Facino RM
J Mass Spectrom; 2003 Sep; 38(9):996-1006. PubMed ID: 14505328
[TBL] [Abstract][Full Text] [Related]
12. Models of protein modification in Tris-glycine and neutral pH Bis-Tris gels during electrophoresis: effect of gel pH.
Hachmann JP; Amshey JW
Anal Biochem; 2005 Jul; 342(2):237-45. PubMed ID: 15935323
[TBL] [Abstract][Full Text] [Related]
13. Generation of antibodies to Di- and trichloroacetylated proteins and immunochemical detection of protein adducts in rats treated with perchloroethene.
Pähler A; Birner G; Parker J; Dekant W
Chem Res Toxicol; 1998 Sep; 11(9):995-1004. PubMed ID: 9760273
[TBL] [Abstract][Full Text] [Related]
14. Actin Cys374 as a nucleophilic target of alpha,beta-unsaturated aldehydes.
Dalle-Donne I; Carini M; Vistoli G; Gamberoni L; Giustarini D; Colombo R; Maffei Facino R; Rossi R; Milzani A; Aldini G
Free Radic Biol Med; 2007 Mar; 42(5):583-98. PubMed ID: 17291982
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical detection of quinol--thioether-derived protein adducts.
Kleiner HE; Rivera MI; Pumford NR; Monks TJ; Lau SS
Chem Res Toxicol; 1998 Nov; 11(11):1283-90. PubMed ID: 9815188
[TBL] [Abstract][Full Text] [Related]
16. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations.
Beretta G; Arlandini E; Artali R; Anton JM; Maffei Facino R
J Pharm Biomed Anal; 2008 Jul; 47(3):596-602. PubMed ID: 18378108
[TBL] [Abstract][Full Text] [Related]
17. Protein modification by acrolein: formation and stability of cysteine adducts.
Cai J; Bhatnagar A; Pierce WM
Chem Res Toxicol; 2009 Apr; 22(4):708-16. PubMed ID: 19231900
[TBL] [Abstract][Full Text] [Related]
18. Competitive binding of a Tris run buffer with chiral crown ether in chiral capillary electrophoresis.
Cho SI; Jung H; Chung DS
Electrophoresis; 2000 Nov; 21(17):3618-24. PubMed ID: 11271479
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of plasma alpha 1-proteinase inhibitor by acrolein: adduct formation with lysine and histidine residues.
Gan JC; Ansari GA
Mol Toxicol; 1989; 2(3):137-45. PubMed ID: 2518664
[TBL] [Abstract][Full Text] [Related]
20. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue.
Liu X; Lovell MA; Lynn BC
Anal Chem; 2005 Sep; 77(18):5982-9. PubMed ID: 16159131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
